[Specific correction of extrapyramidal disorders following neuroleptoanalgesia].
D000818:Animals; D006168:Guinea Pigs; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D051379:Mice; D009025:Morpholines / Q000627:therapeutic use*; D009069:Movement Disorders / Q000188:drug therapy*; D009207:Myoclonus / Q000188:drug therapy*; D009458:Neuroleptanalgesia / Q000009:adverse effects*; D010292:Paresthesia / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D011817:Rabbits; D014326:Tropanes / Q000627:therapeutic use*
D009025:Morpholines; D010880:Piperidines; D014326:Tropanes; D008774:Methylphenidate
Correzione specifica delle turbe extra-piramidali successive a neuroleptoanalgesia.